BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-198@pharmaconomics
DTSTAMP:20260707T015434Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:REPL Phase 2 — RP2 (estimated date)
DESCRIPTION:Phase 2 trial results for RP2 in metastatic uveal melanoma are due ~ Dec 31\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1737953/000110465926009510/tm264822d1_ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/198
URL:https://pharmaconomics.com/e/198
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:REPL catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR